Limitations of randomized controlled clinical trials to depict accurately long-term outcomes in rheumatoid arthritis
- PMID: 9566108
- DOI: 10.1007/s003930050059
Limitations of randomized controlled clinical trials to depict accurately long-term outcomes in rheumatoid arthritis
Similar articles
-
Why randomized controlled clinical trials do not depict accurately long-term outcomes in rheumatoid arthritis: some explanations and suggestions for future studies.Clin Exp Rheumatol. 1997 May-Jun;15 Suppl 17:S27-38. Clin Exp Rheumatol. 1997. PMID: 9266130 Review.
-
Towards an epidemiology of rheumatoid arthritis outcome with respect to treatment: randomized controlled trials overestimate treatment response and effectiveness.Rheumatology (Oxford). 2005 Dec;44 Suppl 4:iv18-iv22. doi: 10.1093/rheumatology/kei056. Rheumatology (Oxford). 2005. PMID: 16306476
-
Trials in rheumatoid arthritis: choosing the right outcome measures--comment on the article by Felson et al.Ann Rheum Dis. 2008 Sep;67(9):1356. doi: 10.1136/ard.2008.094805. Ann Rheum Dis. 2008. PMID: 18697785 No abstract available.
-
Lessons learned from rheumatoid arthritis registries.Joint Bone Spine. 2018 May;85(3):271-274. doi: 10.1016/j.jbspin.2017.12.005. Epub 2017 Dec 12. Joint Bone Spine. 2018. PMID: 29246533 Review. No abstract available.
-
[Levamisole used in rheumatoid arthritis].Acta Rhumatol. 1979 Jul-Sep;3(3):219-30. Acta Rhumatol. 1979. PMID: 11496645 Review. Dutch. No abstract available.
Cited by
-
Etanercept versus etanercept plus methotrexate: a registry-based study suggesting that the combination is clinically more efficacious.Arthritis Res Ther. 2003;5(6):R347-51. doi: 10.1186/ar1005. Epub 2003 Oct 1. Arthritis Res Ther. 2003. PMID: 14680509 Free PMC article.
-
Clinical research quo vadis? Trends in reporting of clinical trials and observational study designs over two decades.J Clin Med Res. 2015 Jun;7(6):428-34. doi: 10.14740/jocmr2115w. Epub 2015 Apr 8. J Clin Med Res. 2015. PMID: 25883705 Free PMC article.
-
Infliximab treatment for rheumatoid arthritis, with dose titration based on the Disease Activity Score: dose adjustments are common but not always sufficient to assure sustained benefit.Ann Rheum Dis. 2004 Feb;63(2):144-8. doi: 10.1136/ard.2003.015933. Ann Rheum Dis. 2004. PMID: 14722202 Free PMC article. Clinical Trial.
-
Dose escalation of infliximab in clinical practice: improvements seen may be explained by a regression-like effect.Ann Rheum Dis. 2004 Apr;63(4):426-30. doi: 10.1136/ard.2003.010967. Ann Rheum Dis. 2004. PMID: 15020338 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical